Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels
Archives of Medical Science · 31.01.2024 · 20 (1) · 8-27
DOI: 10.5114/aoms/183522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Science, online erschienen am 31.01.2024. Verfasst von Bożena Sosnowska und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland. Die Arbeit wurde bisher 42-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Lipoprotein(a) [Lp(a)] is made up of a low-density lipoprotein (LDL) particle and a specific apolipoprotein(a). The blood concentration of Lp(a) is approximately 90% genetically determined, and the main genetic factor determining Lp(a) levels is the size of the apo(a) isoform, which is determined by the number of KIV2 domain repeats. The size of the apo(a) isoform is inversely proportional to the blood concentration of Lp(a). Lp(a) is a strong and independent cardiovascular risk factor. Elevated Lp(a) levels ≥ 50 mg/dl (≥ 125 nmol/l) are estimated to occur in more than 1.5 billion people worldwide. However, determination of Lp(a) levels is performed far too rarely, including Poland, where, in fact, it is only since the 2021 guidelines of the Polish Lipid Association (PoLA) and five other scientific societies that Lp(a) measurements have begun to be performed. Determination of Lp(a) concentrations is not easy due to, among other things, the different sizes of the apo(a) isoforms; however, the currently available certified tests make it possible to distinguish between people with low and high cardiovascular risk with a high degree of precision. In 2022, the first guidelines for the management of patients with elevated lipoprotein(a) levels were published by the European Atherosclerosis Society (EAS) and the American Heart Association (AHA). The first Polish guidelines are the result of the work of experts from the two scientific societies and their aim is to provide clear, practical recommendations for the determination and management of elevated Lp(a) levels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.
- National Institute of Cardiology, Warsaw, Poland.
- 1 Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Cardiology and Adult Congenital Defects, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
- Department of Clinical Cardiology and Cardiovascular Interventions, University Hospital in Krakow, Krakow, Poland.
- Department of Interventional Cardiology and Cardiac Surgery, University of Zielona Gora, Collegium Medicum, Zielona Gora, Poland.
Zitieren
APA
Sosnowska, B., Stepinska, J., Mitkowski, P., Bielecka-Dabrowa, A., Bobrowska, B., Budzianowski, J., Burchardt, P., Chlebus, K., Dobrowolski, P., Gasior, M., Jankowski, P., Kubica, J., Mickiewicz, A., Mysliwiec, M., Osadnik, T., Prejbisz, A., Rajtar-Salwa, R., Wita, K., Witkowski, A., …, & Banach, M. (2024). Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels. Archives of Medical Science, 20(1), 8-27. https://doi.org/10.5114/aoms/183522
Vancouver
Sosnowska B, Stepinska J, Mitkowski P, Bielecka-Dabrowa A, Bobrowska B, Budzianowski J, et al. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels. Archives of Medical Science. 2024;20(1):8-27. doi:10.5114/aoms/183522
BibTeX
@article{Sosnowska2024,
author = {Sosnowska, Bożena and Stepinska, Janina and Mitkowski, Przemyslaw and Bielecka-Dabrowa, Agata and Bobrowska, Beata and Budzianowski, Jan and Burchardt, Pawel and Chlebus, Krzysztof and Dobrowolski, Piotr and Gasior, Mariusz and Jankowski, Piotr and Kubica, Jacek and Mickiewicz, Agnieszka and Mysliwiec, Malgorzata and Osadnik, Tadeusz and Prejbisz, Aleksander and Rajtar-Salwa, Renata and Wita, Kristian and Witkowski, Adam and Gil, Robert and Banach, Maciej},
title = {Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels},
journal = {Archives of Medical Science},
year = {2024},
volume = {20},
number = {1},
pages = {8--27},
doi = {10.5114/aoms/183522}
}
EUVIMED